BioCentury | Feb 20, 2014
Targets & Mechanisms

Preserving the oocyte reserve

...oocytes have become follicle enclosed and attained meiotic arrest." Palmer is CSO of genitourinary company TocopheRx...
...Xetra:MRK), Darmstadt, Germany Sbarro Health Research Organization , Philadelphia, Pa. Temple University , Philadelphia, Pa. TocopheRx...
BioCentury | Dec 9, 2013
Company News

Merck KGaA genitourinary news

...The EMD Serono Inc. subsidiary of Merck launched TocopheRx (Boston, Mass.) to develop the pharma's preclinical...
...in seed funding and MS Ventures will manage the investment and also be represented on TocopheRx's...
...will support development of the program from lead optimization to identification of a clinical candidate. TocopheRx...
Items per page:
1 - 2 of 2
BioCentury | Feb 20, 2014
Targets & Mechanisms

Preserving the oocyte reserve

...oocytes have become follicle enclosed and attained meiotic arrest." Palmer is CSO of genitourinary company TocopheRx...
...Xetra:MRK), Darmstadt, Germany Sbarro Health Research Organization , Philadelphia, Pa. Temple University , Philadelphia, Pa. TocopheRx...
BioCentury | Dec 9, 2013
Company News

Merck KGaA genitourinary news

...The EMD Serono Inc. subsidiary of Merck launched TocopheRx (Boston, Mass.) to develop the pharma's preclinical...
...in seed funding and MS Ventures will manage the investment and also be represented on TocopheRx's...
...will support development of the program from lead optimization to identification of a clinical candidate. TocopheRx...
Items per page:
1 - 2 of 2